| Estimating an EQ-5D-5L value set for China N Luo, G Liu, M Li, H Guan, X Jin, K Rand-Hendriksen Value in Health 20 (4), 662-669, 2017 | 426 | 2017 |
| Monitoring transmissibility and mortality of COVID-19 in Europe J Yuan, M Li, G Lv, ZK Lu International Journal of Infectious Diseases 95, 311-315, 2020 | 374 | 2020 |
| Chinese time trade-off values for EQ-5D health states GG Liu, H Wu, M Li, C Gao, N Luo Value in health 17 (5), 597-604, 2014 | 343 | 2014 |
| Instruction on how to use the Chinese version of the EQ-5D M Li, N Luo China Journal of Pharmaceutical Economics, 49-57, 2009 | 149* | 2009 |
| Cardiac risks associated with antibiotics: azithromycin and levofloxacin ZK Lu, J Yuan, M Li, SS Sutton, GA Rao, S Jacob, CL Bennett Expert opinion on drug safety 14 (2), 295-303, 2015 | 104 | 2015 |
| Developing the Chinese version of the new 5-level EQ-5D descriptive system: the response scaling approach N Luo, M Li, GG Liu, A Lloyd, F de Charro, M Herdman Quality of life research 22, 885-890, 2013 | 91 | 2013 |
| Differences in proxy-reported and patient-reported outcomes: assessing health and functional status among medicare beneficiaries M Li, I Harris, ZK Lu BMC medical research methodology 15 (1), 1-10, 2015 | 85 | 2015 |
| Myocarditis and pericarditis following COVID-19 vaccination: inequalities in age and vaccine types M Li, J Yuan, G Lv, J Brown, X Jiang, ZK Lu Journal of personalized medicine 11 (11), 1106, 2021 | 82 | 2021 |
| Pharmacoeconomic evaluation studies in China: status quo, problems and suggestions M Li, H Li, A Ma China Pharmacy 19 (11), 801-805, 2008 | 70* | 2008 |
| Mortality rate and characteristics of deaths following COVID-19 vaccination G Lv, J Yuan, X Xiong, M Li Frontiers in Medicine 8, 670370, 2021 | 69 | 2021 |
| Age and gender disparities in adverse events following COVID-19 vaccination: Real-world evidence based on big data for risk management X Xiong, J Yuan, M Li, B Jiang, ZK Lu Frontiers in medicine 8, 700014, 2021 | 64 | 2021 |
| A comparison of the scaling properties of the English, Spanish, French, and Chinese EQ-5D descriptive systems N Luo, M Li, J Chevalier, A Lloyd, M Herdman Quality of life research 22, 2237-2243, 2013 | 49 | 2013 |
| Racial/ethnic disparities in the prevalence and trends of autism spectrum disorder in US children and adolescents J Yuan, M Li, ZK Lu JAMA Network Open 4 (3), e210771-e210771, 2021 | 40 | 2021 |
| Democracy and case fatality rate of COVID-19 at early stage of pandemic: a multicountry study L Yao, M Li, JY Wan, SC Howard, JE Bailey, JC Graff Environmental Science and Pollution Research, 1-11, 2021 | 31 | 2021 |
| The effects of lead time and visual aids in TTO valuation: a study of the EQ-VT framework N Luo, M Li, EA Stolk, NJ Devlin The European Journal of Health Economics 14, 15-24, 2013 | 29 | 2013 |
| A comparison of self-reported and proxy-reported health utilities in children: a systematic review and meta-analysis M Jiang, Y Ma, M Li, R Meng, A Ma, P Chen Health and Quality of Life Outcomes 19 (1), 1-13, 2021 | 23 | 2021 |
| The role of cerebrovascular disease and the association between diabetes mellitus and dementia among aged medicare beneficiaries ZK Lu, M Li, J Yuan, J Wu International journal of geriatric psychiatry 31 (1), 92-98, 2016 | 21 | 2016 |
| Antibiotic exposure and the risk of food allergy: evidence in the US Medicaid pediatric population M Li, ZK Lu, DJ Amrol, JR Mann, JW Hardin, J Yuan, CL Cox, BL Love The Journal of Allergy and Clinical Immunology: In Practice 7 (2), 492-499, 2019 | 20 | 2019 |
| Effects and safety of herbal medicines among community-dwelling residents during COVID-19 pandemic: A large prospective, randomized controlled trial (RCT) B Yan, Z Jiang, J Yuan, M Li, J Zeng, J Tang, ZK Lu, H Ding, J Xia, ... Phytomedicine 85, 153403, 2021 | 19 | 2021 |
| Do Chinese have similar health-state preferences? A comparison of mainland Chinese and Singaporean Chinese P Wang, MH Li, GG Liu, J Thumboo, N Luo The European Journal of Health Economics 16, 857-863, 2015 | 18 | 2015 |
